A farewell to arms: streptococcal strategies to cope with innate immunity.

administration of the TREM-1 decoy receptor rTREM-1/ Fc attenuated the proinflammatory cytokine response, improving the outcome [3] . S. pyogenes also produces several proteases and two of these have distinct activities against immunoglobulins (IgGs). The classical cysteine proteinase of S. pyogenes is SpeB, having broad proteolytic activities including IgG degradation [4] . In addition, S. pyogenes secretes one of the best-described bacterial enzymes with glycoside hydrolase activity specific for human IgG. The glycan of IgG is crucial for the stability and conformation of the Fc portion, and deglycosylation of IgG can result in the loss of activation of the complement and a failure to bind to Fc receptors. The activity of EndoS on opsonizing IgG has been shown to lead to a significant reduction in the killing of S. pyogenes in blood compared to untreated IgG [5] . In addition to SpeB and EndoS, S. pyogenes has evolved an IgG-specific endopeptidase, IdeS, which is highly specific for the lower hinge region of IgG [6] . S. pyogenes can also manipulate the innate immune response, as described in the following three examples: complement activation, phagocytosis and neutrophil extracellular traps (NETs). Complement fragments, such as C3a and C5a, are important in host defense because both peptides serve as anaphylatoxins and, similarly to IL-8/CXCL8, they can recruit neutrophils to sites of infection [7] . There are two specific proteases released from S. pyogenes that can target these chemotactic factors, i.e. C5a peptidase-degrading C5a and SpyCEP-processing IL-8/CXCL8, respectively [8, 9] , which, in both Infections with Streptococcus pyogenes , a major human pathogen, are typically of a mild and superficial nature. However, under rare and unfortunate conditions, patients can experience severe and life-threatening complications, such as necrotizing fasciitis and streptococcal toxic shock syndrome [1] . Notably, invasive streptococcal disease can occur in previously healthy individuals with no obvious preceding superficial infection. This has led to the hypothesis that streptococci have to cause a transient bacteremia that facilitates their dissemination within the host’s body. In this issue of the Journal of Innate Immunity , Ochel et al. [2] show that S. pyogenes of the M1 serotype can invade endothelial cells. The study focuses on the tissue-invasive serotype M1 of S. pyogenes , demonstrating that the pathogen can enter the endothelial cells of blood vessels, thereby escaping host defense, and can survive in the cytoplasm of these cells. At a later stage, the bacteria may then spread further, causing systemic and severe infections. S. pyogenes is extremely virulent in the bloodstream, not least via the M-proteins, both surface-associated and released, that may trigger a cytokine storm and other pathologic conditions as is often seen in patients with severe sepsis. A better understanding of these reactions may lead to the discovery of novel diagnostic tools and antimicrobial therapies. One example is TREM-1 (triggering receptor expressed on myeloid cells), a surface molecule expressed on neutrophils and macrophages. Recent findings in an animal model showed that TREM-1 was upregulated during sepsis caused by S. pyogenes and that Published online: June 25, 2014 Journal of Innate Immunity